Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome. (FreeO2 SCA)
Infarction, Myocardial
About this trial
This is an interventional supportive care trial for Infarction, Myocardial
Eligibility Criteria
Inclusion Criteria:
- Patients should have a proven diagnosis of acute high risk coronary syndrome as defined by the American Heart Association:
- myocardial infarction with or without ST segment elevation: Ischemic changes in the electrocardiogram and positive cardiac biomarkers.
- or Unstable angina: Typical or atypical cardiac symptoms, Ischemic electrocardiographic changes, Normal cardiac biomarkers.
Exclusion Criteria:
- inclusion in another study refusing co-enrollment
- chronic obstructive pulmonary disease with CO2 retention
- sleep apnea-hypopnea syndrome with CPAP
- traumatic brain injury
- pregnancy
- Age <18 years
- Mechanical invasive or non-invasive ventilation
- patient needing more than 5 lpm of oxygen to have SpO2 > 95%
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
Control group
FreeO2 with SpO2 target = 92%
FreeO2 with SpO2 target =97%
In this group, the nursing staff administed oxygen supply if necessary with the usual pratice in care unit for 24 hours after myocard infarction. In this group the SpO2 was recorded any time with FreeO2 device - recording mode.
In this group oxygen flow was automatically adjusted with the FreeO2 device (automatic titration of oxygen flow) to achived SpO2 target set by clinicial for 24 hours after myocard infarction. In this group, the SpO2 target was set at 92%.
In this group oxygen flow was automatically adjusted with the FreeO2 device (automatic titration of oxygen flow) to achived SpO2 target set by clinicial for 24 hours after myocard infarction. In this group, the SpO2 target was set at 97%.